abstract |
The present invention provides a liquid formulation comprising propylene glycol and an effective amount of a cardiac contractile vasodilator, angiotensin converting enzyme inhibitor, or a combination of a cardiac contractile vasodilator and an angiotensin converting enzyme inhibitor, and heart disease and / or hypertension. It relates to the use of the formulation for treating. |